Holen Sie sich die Stockscreener-App
4.13
0.24%
0.010
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
Finanzdaten der Oramed Pharmaceuticals Inc-Aktie (ORMP)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Research and Development |
100.00%
-
|
1.594 | 1.988 | - | - |
| Operating Income/Loss |
24.41%
-2.766
|
-3.659 | -5.672 | -2.427 | -2.489 |
| Nonoperating Income/Loss |
131.32%
103.74
|
44.85 | 15.18 | 61.47 | 15.37 |
| Income/Loss From Continuing Operations Before Tax |
105.48%
101.59
|
49.44 | 9.797 | 59.45 | 13.13 |
| Income Tax Expense/Benefit, Current |
26.28%
1.634
|
1.294 | - | - | - |
| Income Tax Expense/Benefit, Deferred |
21.80
|
- | - | - | - |
| Income Tax Expense/Benefit |
110.52%
23.43
|
11.13 | -0.212 | 11.06 | -0.126 |
Net Income/Loss
|
104.01%
78.16
|
38.31 | 10.01 | 48.39 | 13.26 |
| Basic Average Shares |
0.65%
41.04
|
40.77 | - | 41.76 | 41.74 |
| Diluted Average Shares |
1.27%
42.50
|
41.97 | - | 42.77 | 42.61 |
| Basic Earnings Per Share |
102.13%
1.90
|
0.94 | - | 1.16 | 0.32 |
| Diluted Earnings Per Share |
102.20%
1.84
|
0.91 | - | 1.13 | 0.31 |
3.09%
0.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):